Karger Publishers automates licensing process with CCC solution - 04 Apr 2013 Licensing solutions provider Copyright Clearance Center, Inc. (CCC), US, has announced that Switzerland-based Karger Medical and Scientific Publishers has implemented CCC's RightsLink Premium to manage copyright permissions for its journals and books. RightsLink Premium supports a publisher's online strategy by providing its customers with instant reprint and permission services, 24 hours 7 days, worldwide, integrating seamlessly with online content wherever it resides: on a Website, mobile application, or archive server, or at a third-party aggregator. It automates the entire licensing process, from secure order processing and workflow management to real-time reporting and royalty payments while adapting to each publisher's unique licensing requirements and business processes. Karger Publishers is an international biomedical publisher. Currently, production comprises 90 subscription and open access journals and about 50 book titles per year, both research and clinical, the majority of which are in English.

CC-BY license option now available on 42 NPG journals - 03 Apr 2013 Scientific publisher Nature Publishing Group (NPG), UK, now offers authors a wider choice of journals using the Creative Commons Attribution (CC-BY) license. NPG and its publishing partners have introduced the CC-BY license option on twenty-two further journals, including Nature Communications. Of the 61 NPG journals that are open access or have open access options, 42 now offer the choice of CC-BY as one of the options. The Wellcome Trust and RCUK revised public access policies came into effect on April 1, 2013. These funders will require a CC-BY license when their funds are used to pay open access article processing charges. Nature Communications will offer CC-BY licenses at an APC of $5200, for authors submitting manuscripts on or after April 1. Two non-commercial CC license options remain available, and the APC for these has been reduced to $4800, from the current APC of $5000. Twenty-one of the journals introducing a CC-BY option are published by NPG on behalf of publishing partners and either offer open access options, or are open access journals. They join Scientific Reports and the 19 NPG-owned academic journals that introduced CC-BY in 2012. The partner journals that have introduced the CC-BY licence are: BoneKEy Reports, The ISME Journal, Emerging Microbes&Infections, European Journal of Human Genetics, Eye, Journal of Cerebral Blood Flow and Metabolism, Cell Death and Differentiation, Cell Death and Disease, Cell Research, Genetics in Medicine, Heredity, Laboratory Investigation, Modern Pathology, Molecular Therapy, Molecular Therapy - Nucleic Acids, Light: Science&Applications, Spinal Cord, The EMBO Journal, EMBO reports, Molecular Systems Biology and the British Dental Journal. The CC BY license will be available to authors choosing open access publication options in these journals, in addition to the two non-commercial Creative Commons (CC) licenses currently on offer. In addition, The EMBO Journal, EMBO reports and Molecular Systems Biology have adopted CC0 waiver for the release of published datasets and figure source data. CC0 allows unrestricted re-use of research data. Data available on nature.com's linked data platform is also available under CC0. Other NPG publishing partners are also considering introducing CC-BY in due course. The CC BY license allows for articles to be distributed and amended, including for commercial opportunities. Papers can be developed upon, as long as attribution is given to the original work and its authors. An APC is levied per article accepted for publication for authors choosing to make their work open access.

CCC and BISG partner to present a live, three-part webcast series - 28 Feb 2013 Licensing solutions provider Copyright Clearance Center, Inc. (CCC), US, has announced a partnership with book trade association Book Industry Study Group (BISG), to present a live, three-part webcast series 'The Business of Rights' to help publishers, authors and agents better understand, manage and monetize content rights. The co-produced series is one of a number of CCC educational events to inform the trade publishing industry about today's rights and licensing risks and opportunities. Participants will learn about the changing rights landscape and about ways to generate new revenue and increase operational efficiencies in this era of transformation and uncertainly. The first webcast, 'Understanding Rights in a Changing World: Licensing Risks and Opportunities Created by a Global Marketplace,' will be presented on March 5; the second, 'Managing and Organizing Rights in a Time of Change: Tools and Services for Efficiently and Effectively Organizing Rights,' on March 12; and the third, 'Monetizing Rights in a Time of Change: Good Rights Management is Good Business Management,' on March 19. All webcasts are one hour long and begin at 1:00 pm ET.

Creative Commons License to apply to all OA content published by De Gruyter - 15 Feb 2013 Academic publisher De Gruyter, Germany, and Versita will be publishing all Open Access content under the uniform application of Creative Commons license CC BY-NC-ND, effective immediately. This means that publications may now be copied, disseminated, and otherwise made public by users under the conditions that the name of the author/copyright owner must be mentioned in the manner requested by the author/copyright owner; the publication and its content may not be used in its Open Access format for commercial purposes; and the publication and its content may not be edited, modified, or otherwise changed. Creative Commons license CC BY-NC-ND is already the basis for the publishing contract concluded just days ago between De Gruyter and the Max Planck Society for the publication of Open Access books. In 2012 De Gruyter and Versita published over 10,000 Open Access articles in some 300 journals. Since 2009 a large number of books and book chapters have also been published under the Open Access standard. In addition to publication in dedicated Open Access journals, De Gruyter and Versita offer OA publication in established subscription journals (so-called Hybrid Open Access).

Portland Press invites authors to use Creative Commons Attribution licence for papers published in ASN NEURO and Bioscience Reports - 04 Feb 2013 Portland Press Limited, the not-for-profit publishing subsidiary of the Biochemical Society, has announced that it will invite authors to use the CC-BY (Creative Commons Attribution) licence for papers published in its two Gold Open Access journals - ASN NEURO and Bioscience Reports. This allows authors to comply fully with recent changes in funding body policies. This change in licensing arrangements also applies to papers published under the Opt2Pay (Gold Open Access) option in Portland Press's hybrid journals, which include the long-standing, core title the Biochemical Journal, Biochemical Society Transactions and the clinical research publication Clinical Science. Portland Press Limited is a not-for-profit, innovative publisher of journals, books and electronic resources in the biochemical, cellular and molecular life sciences. The surplus from the sale of publications is returned to the scientific community via the activity of the Biochemical Society.